Our Resource Meetups are free online gatherings for people affected by colorectal cancer seeking access to resources and peer-to-peer support.
Our Clinical Trial Finder is a one-stop place to find and learn more about high-impact research studies for CRC patients. The current data are limited to MSS (microsatellite-stable) and stage IV CRC patients.
Our Path to a Cure report is our plan for the future. This plan is not just for Fight CRC, but for everyone who is willing to champion this cause.
Shop our online store to raise awareness everywhere you go! From t-shirts and fanny packs to patient education resources, we have a little bit of everything.
Raise Awareness. Be an Advocate. Host an Event.
Clinical trial’s patient recruitment status
Phase of the clinical trial that is recruiting (I, II, or III)
A flag to indicate whether the trial is an immunotherapy trial
Prior Immunotherapy Allowed
Whether the clinical trial is open to patients who have received prior immunotherapy
A flag to indicate whether the trial is specifically targeting colon cancer, rectal cancer, or colorectal cancer patients
Therapeutics used in the clinical trial
Histologically confirmed diagnosis of colorectal carcinoma with KRAS G12C mutation in tumor tissue.
Prior receipt of 1st line treatment in advanced CRC with a fluoropyrimidine-based chemotherapy regimen containing either oxaliplatin or irinotecan, and radiographically documented progression of disease on or after treatment.
Prior treatment with a therapy targeting KRAS G12C mutation (e.g., AMG 510).
Prior treatment with an anti-EGFR antibody (e.g., cetuximab or panitumumab).
Active brain metastasis
Trial ID number from clinicaltrials.gov or other database
Date Trial Added
Date on which the clinical trial was added to the clinicaltrials.gov website
Date on which the clinical trial was updated on the clinicaltrials.gov website
Join the fight against colorectal cancer.